Dr. Mancebo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2320 Freeway Dr
Mount Vernon, WA 98273Phone+1 360-814-6800
Education & Training
- SUNY Downstate Health Sciences UniversityResidency, Dermatology, 2016 - 2019
- State University of New York Downstate Medical Center College of MedicineClass of 2015
Certifications & Licensure
- WA State Medical License 2023 - 2026
- NY State Medical License 2019 - 2024
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Dermatoscopic features and potential pitfalls of artificial intelligence-based analysis of benign acral pigmented lesions in Black patients: A multicenter observationa...Mariela Mitre, Sharif Hosein, Andia Mitri, Nicholas R Kurtansky, Silvia E Mancebo
Journal of the American Academy of Dermatology. 2024-07-01 - 2 citationsEnfortumab vedotin toxic epidermal necrolysis-like blistering dermatosis: A case series and review of the literature.Bushra Khanjar, Zane Sejdiu, Mariela Mitre, Silvia Mancebo, Cynthia Magro
JAAD Case Reports. 2024-01-01 - 3 citationsVulvovaginal Pyoderma Gangrenosum in a Patient Treated With Ocrelizumab for Multiple Sclerosis.Alyssa N Breneman, Ariel E Eber, Hoosna Haque, Libby Levine, Anca Askanase
Journal of Lower Genital Tract Disease. 2022-04-01
Journal Articles
- Performance of Gene Expression Profile Tests for Prognosis in Patients with Localized Cutaneous MelanomaMichael A Marchetti, Silvia E Mancebo, JAMA Dermatology
Authored Content
- Performance of Gene Expression Profile Tests for Prognosis in Patients with Localized Cutaneous MelanomaJuly 2020
- Performance of Gene Expression Profile Tests for Prognosis in Patients with Localized Cutaneous MelanomaJuly 2020
- Performance of Gene Expression Profile Tests for Prognosis in Patients with Localized Cutaneous MelanomaJuly 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: